Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours

Daphne W. Dumoulin*, Paolo Bironzo, Francesco Passiglia

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
16 Downloads (Pure)

Abstract

Despite the progress in outcomes seen with immunotherapy in various malignancies, including nonsmall cell lung cancer, the benefits are less in small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours. New effective treatment options are needed, guided via more in-depth insights into the pathophysiology of these rare malignancies. This review comprehensively presents an overview of the clinical presentation, diagnostic tools, staging systems, pathophysiology and treatment options for these rare thoracic cancers. In addition, opportunities for further improvement of therapies are discussed.

Original languageEnglish
Article number220174
JournalEuropean Respiratory Review
Volume32
Issue number167
DOIs
Publication statusPublished - 1 Mar 2023

Bibliographical note

Publisher Copyright:
© The authors 2023.

Fingerprint

Dive into the research topics of 'Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours'. Together they form a unique fingerprint.

Cite this